Intersect Investments

Running head:  PROBLEM SOLUTION: GENE ONE

Problem Solution: Gene One
Nadia A. McIntosh
University of Phoenix

 
Problem Solution: Gene One
Gene One, a private, growing biotechnology company, is one of the best and brightest companies in their field. Its technology has helped thousands as they deliver groundbreaking products in their field to help produce gene technology that helped to produce some of the freshest crops. Not only were they producing groundbreaking technology, but their products have helped them to grow into a $400 million company in just eight short years.
Even though Gene One is a company that is far from poor, they are forced to make new changes to the company to meet their goals. Leadership changes at the Food and Drug Administration, expectations of Wall Street, and the changing laws of the Securities and Exchange Commission and the Sarbanes-Oxley Act have forced Gene One into changing from a private to a public company. In order to keep up with the changing demands, the CEO and his board of directors have devised a strategy that will not only help them reach their growth target of 40%, but will help to establish the company as a strong competitor, and show Wall Street that Gene One has what it takes to survive as a public company. Little did Gene One know that by making these changes they would be faced with opposition and more obstacles than they came into the game with. As Gene One exposes its strategy, they are met with disapproval not from the outside, but within the top management team. One team member has resigned, and another one is threatening. Not only that, but Gene One is in danger of violating important laws in relation to SEC.  They also have no stable corporate culture, and the leadership is ...
Word (s) : 4192
Pages (s) : 17
View (s) : 608
Rank : 0
   
Report this paper
Please login to view the full paper